CD 1530 Size:Contact [email protected] for quotation InChi: InChI=1S/C11H14N4S/c1-9(10-5-2-3-6-12-10)13-14-11(16)15-7-4-8-15/h2-3

InChi: InChI=1S/C11H14N4S/c1-9(10-5-2-3-6-12-10)13-14-11(16)15-7-4-8-15/h2-3

Recombinant BCG With Bacterial Signaling Molecule Cyclic di-AMP as Endogenous AdjuvantInduces Elevated Immune Responses After Mycobacterium tuberculosis Infection

5-dioxoimidazolidine-based P2X(7) receptor antagonists as constrained analogues of KN62

InChiKey: SPMFEULFGGPQLN-UHFFFAOYSA-N

male Sprague-Dawley rats) treatment abolishes the reduction of the severity of abstinence signs induced by Rhodiola rosea administration in nicotine-dependent rat

CD 1530 Size:Contact [email protected] for quotation InChi: InChI=1S/C11H14N4S/c1-9(10-5-2-3-6-12-10)13-14-11(16)15-7-4-8-15/h2-3Target: RAR, RAR and RAR Ki: 150, 1500, and 2750 nM CD1530 is a potent and selective RAR receptor agonist with Ki values of 150, 1500 and 2750 nM for RAR, RAR and RAR receptors, respectively . In addition, CD1530 shows moderate RAR selectivity in the transcriptional assay with AC50 value of 1. 8 nM. RAR is present in the majority of tissues while the distribution of RAR and is more selective . RAR mediated retinoic acid (RA) induced growth arrest and